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 18 
Abstract  19 
Activation induced proliferation and clonal expansion of antigen specific lymphocytes is a 20 
hallmark of the adaptive immune response to pathogens. Recent studies identify two distinct 21 
control phases. In the first T and B lymphocytes integrate antigen and additional costimuli to 22 
motivate a programmed proliferative burst that ceases with a return to cell quiescence and 23 
eventual death. This proliferative burst is autonomously timed, ensuring an appropriate 24 
response magnitude whilst preventing uncontrolled expansion. This initial response is subject 25 
to further modification and extension by a range of signals that modify, expand and direct the 26 
emergence of a rich array of new cell types.  Thus, both robust clonal expansion of a small 27 
number of antigen specific T cells, and the concurrent emergence of extensive cellular 28 
diversity, confers immunity to a vast array of different pathogens. The in vivo response to a 29 
given pathogen is made up by the sum of all responding clones and is reproducible and 30 
pathogen specific. Thus, a precise description of the regulatory principles governing 31 
lymphocyte proliferation, differentiation and survival is essential to a unified understanding of 32 
the immune system.  33 
 34 
Introduction 35 
According to classic two-signal theory, lymphocytes face a binary decision when stimulated 36 
by antigen and must choose between tolerance (death) and activation (proliferation). A second 37 
signal is needed to tip the balance from one state to the other. Careful studies of the control of 38 
T and B cells are substantially modifying this view and replacing the binary decision with a 39 
quantitative signal integration model that tempers the overall strength and type of response to 40 
the nature of the threat. As a result, the magnitude and duration of the immune response must 41 
be seen as continuously variable. How this T cell behaviour is modulated, at molecular, single 42 
cell and population levels to achieve such a rich set of alternative outcomes remains under 43 
intensive investigation. Figure 1 illustrates the control of lymphocyte proliferation as a two-44 
stage process with each naive cell integrating activation signals, stochastic probabilities and 45 
ongoing signals to control the rich heterogenous population outcome. 46 
 47 
Early programming cooperates with ongoing signal integration to control the response 48 
magnitude 49 
In reviewing progress to date, it is helpful to distinguish two separate stages for lymphocyte 50 
activation.  In the first, an autonomously programmed response, leading to multiple changes in 51 
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fate are motivated by the initial stimuli. T cells divide several times subsequent to removal of 52 
stimuli.  In CD8+ T cells this can be after a very brief initial exposure [1-4] whereas in CD4+ 53 
T cells a longer antigen exposure is required to commit cells to an autonomous proliferative 54 
burst  [5,6]. A similar initial autonomous clonal division is observed in B cells [7-9]. In the 55 
second phase of control, the early cell programming is further modified by ongoing signals. 56 
For example, T cells modify their own environment by producing the growth factor IL-2 that 57 
can promote their continued division [10]. As signalling inputs can operate simultaneously on 58 
both phases of the response it can be difficult to determine individual control mechanisms. 59 
Costimulatory signals as well as cytokines and chemokines all play fundamental roles in 60 
regulating one or more parameters that determine the final cell numbers. Additional features of 61 
signal control, such as increased TCR affinity, enhanced dose, duration or mechanical 62 
properties of TCR-pMHC contacts or prolonged antigen exposure also result in a greater 63 
response magnitude, with increased rounds of cell division or greater recruitment of cells into 64 
division [11,12].  In many cases, the early expansion rate of activated T cells is unchanged in 65 
these systems. Instead, the duration of their expansion is increased [2,11,12] suggesting an 66 
equal proliferation rate of activated cells with more cells dropping out of division or dying 67 
sooner under weak stimulation conditions.  68 
 69 
For T cells the extent of the initial proliferative burst is a major determinant of response 70 
magnitude in vitro and in vivo. The average number of divisions undergone can vary with 71 
stimulation. T cells integrate all the signals they receive through the TCR, costimulatory 72 
molecules and cytokines receptors to determine the size of the initial burst, referred to as their 73 
initial ‘division destiny’ (DD) [13]**. Multiple contributions to DD, provided at the same time, 74 
added arithmetically allowing predictions to be made for the final response. In this study the 75 
authors demonstrate that many different combinations of costimulatory signals are capable of 76 
adding to a significant response outcome. These experiments also highlight control of the 77 
second phase of the T cell response: Cytokines such as IL-2 and IL-4 play both a major role in 78 
initiating, as well as sustaining / extending cell division beyond their initial autonomous DD. 79 
This maintenance was shown to be particularly important for T cells that have migrated to sites 80 
of infection or inflamed tissue [14,15]. T cells modulate IL-2 production and integration of IL-81 
2 signals as a mechanism of paracrine communication in order to fine tune and optimise the 82 
response magnitude [10,16,17]. Furthermore, although the proliferative effect of a particular 83 
stimulus can act predominantly on initial programming, it may also have alternate modulatory 84 
roles during the subsequent progression of the response. For instance, CD28 signalling 85 
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increases IL-2 production and sensitivity [18]. If IL-2 is blocked, the CD28 signal is still 86 
effective at programming and promoting division destiny changes into naïve T cells but the 87 
signal must be received prior to the first division to have an effect [13]. Later engagement of 88 
CD28 alters downstream fate selection during the response without having any further 89 
proliferative impact [19]. 90 
 91 
The regulatory precision of the initial burst of proliferation and return to quiescence by 92 
stimulated T and B cells [9] suggested a common mechanism might be found. This proved 93 
correct. The cell division-promoting proto-oncogene Myc [20]** is induced upon activation 94 
and lost over time until a minimal threshold is crossed, and division ceases. Rather than diluting 95 
by division, as was expected, Myc levels degraded over time at a predictable rate that was 96 
faithfully passed on to daughter cells independently of division number. As expected for this 97 
form of control, the level of Myc protein induced after activation was found proportional to the 98 
strength and number of signals received by the cell, and its level highly correlated with 99 
subsequent DD. Therefore, Myc translates the signals the cell receives into the time that each 100 
founder cell is given to divide before returning to quiescence [20].  101 
Furthermore, in addition of providing stimulatory signals on their own, inflammatory signals 102 
such as IL-12 and IFN-α can increase sensitivity to IL-2 signalling [14,21,22]. Continuous 103 
signalling via IL-2 or other cytokines slows the loss of Myc protein and therefore extending 104 
the period of time for which the cells can divide [20] [23]* [24]. Understanding how these 105 
factors function as part of a subcellular network, combining and cooperating to determine the 106 
ultimate proliferative potential of an individual T cell remains a major objective in the field of 107 
lymphocyte biology. 108 
 109 
These studies may have a further counterpart in the germinal centre. During affinity maturation 110 
germinal centre B cells travel from the light zone where they undergo positive selection to the 111 
dark zone and undergo somatic hypermutation [25]. Interaction with Tfh cells during the 112 
positive selection process provides proliferation and survival signals. In this context Myc 113 
expression is induced through interaction with Tfh cells and is seen in a proportion of, 114 
presumably, recently activated cells [26,27].  Affinity dependent stimulation is thought to 115 
control proliferation and survival with low affinity B cells dying in the light zone while 116 
dysfunctional BCR induced through mutation leads to cell death in the dark zone [28,29] [30]*. 117 
In parallel with the control of T and B cell DD, it seems likely that higher affinity B cell clones 118 
receive stronger stimuli and accumulate more Myc, extending their duration of proliferation in 119 
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the dark zone and therefore licensing these clones for more extensive somatic hypermutation 120 
[29]. 121 
 122 
Clonal concordance, probabilistic events and fate inheritance shape the response  123 
The proliferative and phenotypic profile of a responding T cell population is highly 124 
heterogeneous, even under highly controlled in vitro conditions. Despite this extensive 125 
diversity, there is a remarkable concordance of the proliferative fate within a clonal family 126 
while a considerable disparity is observed between different clones even in response to 127 
identical stimulation conditions [31] [32]* [33]*. In vivo studies have also demonstrated 128 
extensive heterogeneity in clone size and a distinct correlation between clonal proliferative 129 
potential and cellular phenotype [34-39]. The phenotypic correlation with clonal burst size 130 
points to a role for both heritability and division as determinants of the emergence of cellular 131 
heterogeneity [35,36,40]. This is complemented by studies that have elucidated a role for 132 
division progression in regulating specific components of T cell differentiation, such as 133 
cytokine production, cytotoxicity and surface marker expression [40-45]. 134 
 135 
Although there is a clear influence of clonal membership on division progression and 136 
phenotype, in vivo studies demonstrate substantially greater intraclonal diversity than the 137 
striking concordance observed in vitro [32,37,38]. TCR signal quality strongly determines the 138 
response outcome on a population basis, and although weakly stimulated cells expand less, 139 
many are still able to acquire effector functions and differentiate into memory cells [11,46,47]. 140 
Therefore the fate of T cell clones is not controlled by the TCR ligation quality alone, but TCR 141 
ligation works in concert with quantitative integration of additional signalling and stochastic 142 
events to determine the fate outcome of the clonal progeny [13,33,35] [46]** [48] [49]* 143 
[50,51].   144 
 145 
Many of the above studies highlight early stochasticity and familial heritability as key drivers 146 
of emergent heterogeneity. Several different models have been proposed to explain the 147 
diversity observed in T cell fates. The concept of asymmetric division of the founder cell 148 
resulting in two distinct fate outcomes of the daughter cells and their progeny has been 149 
proposed as a determinant of T cell fate and population heterogeneity [5,52-54]. Recent studies 150 
have proposed a role for the polarised segregation of Myc and subsequent asymmetric 151 
inheritance of metabolic programming as a determinant of CD8+ T cell fate selection [55,56]. 152 
However, the uneven inheritance of Myc between first-division T cells is at odds with its role 153 
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as a regulator of the highly symmetrical clonal phenomenon of DD [20].  In an alternative 154 
model the strong familial concordance in concert with early stochasticity are sufficient to 155 
describe the emergence of the clonal diversity [46,57]. Computational descriptions of clonal 156 
heterogeneity have also highlighted the capacity to resolve patterns of T and B cell 157 
diversification without the requirement of asymmetric fate segregation [50,58]. Furthermore, 158 
impairment of the capacity of cells to polarise their contents does not hinder the generation of 159 
lymphocyte diversity [59]. 160 
 161 
Recruitment into division as a first step directing the response magnitude 162 
The number of cells recruited into an immune response is another key determinant of response 163 
magnitude. Two main factors determine the number of cells recruited into division: firstly, the 164 
induction of a new survival program driven by the strength of stimulation selecting for strongly 165 
activated cells to survive [60]. Secondly, whether the surviving cells reach the activation 166 
threshold to enter proliferation. On a single cell level this threshold is controlled by the sum of 167 
TCR affinity and dose [12] [61]* [62,63] and other signals received by the cells. Consistent 168 
with the mechanism of signal addition, IL-2 or additional costimulation increases this precursor 169 
frequency and promotes the entry of weakly stimulated cells into division [61,64-66]. Similarly 170 
stimulation through the costimulatory receptor CD27 lowers the affinity threshold required for 171 
activation, recruiting more low affinity clones into the response, potentially as a measure to 172 
broaden the subsequent memory pool repertoire [67].  173 
On a population level, whether a response is observed is determined by the sum of all individual 174 
outcomes and the complex interaction between these cells and the molecules they produce. 175 
This can be described as a collective decision made by the T cell population [68]. IL-2 produced 176 
by strongly activated cells plays a critical role in this activation phase, as some low affinity T 177 
cells can reach the threshold to enter division through integration of IL-2 produced by strongly 178 
activated cells. The response rate of a mixed population of high and low affinity cells can be 179 
modelled and predicted accurately using a dynamic system incorporating IL-2, IL2R and PIK3 180 
levels controlling the accumulation of Cyclin D to reach the threshold of cell cycle entry [69]** 181 
demonstrating how the signal integration by individual cells controlling their fates fine tunes 182 
the overall response on the population basis.  183 
 184 
Survival as an additional and independent mechanism shaping the immune repertoire 185 
The survival of activated T cells critically underpins the ability to form an immune response. 186 
This process is carefully regulated by a quantitative balance between pro- and anti-apoptotic 187 
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members of the Bcl-2 family proteins of the intrinsic apoptotic pathway (reviewed in [70]). A 188 
survival program is induced after T activation, that is distinct from their naïve survival program 189 
and operates simultaneously but independently to the proliferation program [71,72]. Both pro-190 
survival and pro-apoptotic proteins are induced by T cell activation signals through the TCR, 191 
costimulatory molecules (i.e. CD28) or cytokines such as IL-2 [60,73-75]. A similar 192 
quantitative switch in survival programs occurs in B lymphocytes [70,76]. In cells receiving 193 
strong signals this balance favours a pro-survival state, however low affinity populations are 194 
more sensitive to shaping through differential survival as stimulation with a lower affinity TCR 195 
or a reduction in costimulatory signals and cytokines, favours death and the elimination of 196 
weaker responders [75,77-79]. This points to a key function in the regulation of the response 197 
quality.  198 
As the lymphocyte survival program is initiated by many of the same signals as proliferation it 199 
is often difficult to distinguish the relative importance of contributions of these processes in 200 
shaping the immune response; however several lines of evidence suggest their regulation is 201 
independent, and can be uncoupled. For instance, CD28 signalling and other growth factors 202 
promote survival in the absence of proliferation [80]. CD8+ T cells deficient in the kinase Erk2 203 
[81] or the transcription factor Bach2 [82] have been shown to have no defect in proliferative 204 
potential, but have a reduced response magnitude due to impaired survival. Furthermore the 205 
rate and extent of clonal expansion in strongly stimulated cells is not greatly impacted by cell 206 
death. When pro-apoptotic molecule Bim is deleted or pro-survival molecule Bcl-2 is 207 
overexpressed in T or B lymphocytes they undergo the same number of divisions in response 208 
to a given stimulus irrespective of the enhanced cell survival [13,20,83,84]. A similar effect 209 
can be observed in vivo, with Bim-deficient  CD8+ T cells expanding to the same extent but 210 
taking longer to contract [85], further demonstrating the independence of cell division and 211 
survival. The significance of this is highlighted by the consequences of changes to either 212 
parameter. The combined effect of small changes in survival or DD time synergise to a greatly 213 
enhanced response when applied in combination and can be predicted by combining the 214 
probability distributions for each timer [20]. 215 
 216 
 217 
Conclusions: 218 
When the number of alternative cell fates, and the large number of known modifiers are 219 
enumerated, the regulation of T and B cell responses appears impossibly complex. When 220 
combined with the fine detail of cellular niches in different tissues, and the potential for 221 
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transient and persistent signal exposure, it is easy to imagine a daunting combinatorial problem 222 
for control. This pessimistic view is at odds with the general observation that immune responses 223 
are typically robust and reproducible, and many features of cell responses can be recreated in 224 
much simpler in vitro environments. 225 
In resolving this paradox, we suggest that a timed cellular program, that includes an automated 226 
return to quiescence and even eventual death, can serve as a powerful new paradigm for 227 
interpreting the complex control of T, B and GC cell responses. Manipulation of this core 228 
cellular program by multiple modifying inputs provides the foundation for building a 229 
reproducible, but highly regulated system. Such a model can also help explain how the present 230 
complex system may have evolved from more primitive developmental states that utilised a 231 
higher level of cellular autonomy to affect an adaptive immune outcome [7]. We envisage that 232 
continued work on this activation paradigm with increasingly quantitative tools will deliver 233 
scalable models with the power of prediction and significant potential for immune system 234 
control. 235 
 236 
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Figure legends 573 
 574 
Figure 1. An autonomous self-limiting response underlies T and B cell activation. All 575 
lymphocytes receive and process a large number of signals from their environment, antigen 576 
and accessory cells. These signals serve to set timers for the burst of division and the eventual 577 
death of these cells, as well as either division-linked or timed differentiation changes. Similar 578 
cells do not perceive signals in identical manner, leading to clonal family dependent variation 579 
that may have a stochastic basis (1). All cell functions governing this initial internal immune 580 
program can be affected by external signals, and further fate changes regulated by division or 581 
time ensures sensitive and broad ranging fate control (2, 3).  582 
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